DYRK1A and Down syndrome: Conversely, DYRK1A overexpression is implicated in some of the more severe clinical manifestations of trisomy 21 (Down syndrome)3–5, including childhood acute megakaryoblastic leukemia6, disrupted neurodevelopment7,8, early onset Alzheimer’s disease9,10, and decreased risk of solid tumors11,12.